Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - eltrombopag olamine 31.9 mg eqv eltrombopag - tablet, film coated - 25mg - eltrombopag olamine 31.9 mg eqv eltrombopag 25mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - eltrombopag olamine 63.8 mg eqv eltrombopag - tablet, film coated - 50mg - eltrombopag olamine 63.8 mg eqv eltrombopag 50mg

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 25mg - eltrombopag (eltrombopag olamine) 25mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 50mg - eltrombopag (eltrombopag olamine) 50mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 75mg - eltrombopag (eltrombopag olamine) 75mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 12.5mg - eltrombopag (eltrombopag olamine) 12.5mg - hematopoietic agents

Canada - English - Health Canada

apotex inc - eltrombopag (eltrombopag olamine) - tablet - 25mg - eltrombopag (eltrombopag olamine) 25mg

Canada - English - Health Canada

apotex inc - eltrombopag (eltrombopag olamine) - tablet - 50mg - eltrombopag (eltrombopag olamine) 50mg

Israel - English - Ministry of Health

novartis israel ltd - eltrombopag as olamine - film coated tablets - eltrombopag as olamine 25 mg - eltrombopag - eltrombopag - revolade is indicated for the treatment of patients aged 6 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e.g. corticosteroids, immunoglobulins)revolade is indicated for the treatment of adult patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.revolade is indicated for the treatment of thrombocytopenia in adult patients with chronic hepatitis c to allow the initiation and maintenance of interferon-based therapy.revolade is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 6 years and older with severe aplastic anemia.

Israel - English - Ministry of Health

novartis israel ltd - eltrombopag as olamine - film coated tablets - eltrombopag as olamine 50 mg - eltrombopag - eltrombopag - revolade is indicated for the treatment of patients aged 6 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e.g. corticosteroids, immunoglobulins)revolade is indicated for the treatment of adult patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.revolade is indicated for the treatment of thrombocytopenia in adult patients with chronic hepatitis c to allow the initiation and maintenance of interferon-based therapy.revolade is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 6 years and older with severe aplastic anemia.